Psagot Value Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-25
Closed -$1K 196
2023
Q4
$1K Buy
+25
New +$1.33K ﹤0.01% 496
2023
Q3
Sell
-108
Closed -$6K 517
2023
Q2
$6K Sell
108
-17,657
-99% -$922K ﹤0.01% 370
2023
Q1
$874K Sell
17,765
-2,335
-12% -$110K 0.36% 62
2022
Q4
$930K Buy
20,100
+2,100
+12% +$90.9K 0.27% 75
2022
Q3
$697K Buy
18,000
+16,000
+800% +$642K 0.2% 80
2022
Q2
$75K Sell
2,000
-3,500
-64% -$142K 0.02% 228
2022
Q1
$244K Sell
5,500
-40,200
-88% -$1.74M 0.05% 181
2021
Q4
$1.94M Sell
45,700
-43,900
-49% -$1.84M 0.37% 56
2021
Q3
$3.89M Hold
89,600
0.67% 36
2021
Q2
$3.83M Buy
89,600
+6,000
+7% +$252K 0.14% 88
2021
Q1
$3.23M Buy
83,600
+15,500
+23% +$587K 0.07% 137
2020
Q4
$2.45M Buy
+68,100
New +$2.45M 0.06% 140
2020
Q3
Sell
-470
Closed -$17K 398
2020
Q2
$17K Buy
+470
New +$16.9K ﹤0.01% 341
2019
Q2
Sell
-8,000
Closed -$307K 411
2019
Q1
$307K Buy
+8,000
New +$306K 0.01% 238
2014
Q2
Sell
-2,100
Closed -$28K 406
2014
Q1
$28K Buy
2,100
+1,910
+1,005% +$25.1K ﹤0.01% 417
2013
Q4
$2K Buy
+190
New +$2.25K ﹤0.01% 420

Other funds holding BSX

Psagot Value Holdings's BSX Position: Q1 2024 in Review

Psagot Value Holdings sold out of Boston Scientific (BSX) in Q1 2024, closing a stake of 25 shares — an estimated $1K sold.

Psagot Value Holdings first reported a position in BSX in Q4 2013 and held it in 16 quarters. The position peaked at $3.89M in Q3 2021. 1,222 funds tracked by Wall St. Rank hold BSX as of Q1 2024.

  • Psagot Value Holdings reported no remaining Boston Scientific position as of Q1 2024 after selling out during the quarter.
  • Psagot Value Holdings sold 25 Boston Scientific shares in Q1 2024, an estimated $1K.
  • Psagot Value Holdings first reported a position in Boston Scientific in Q4 2013 and held it in 16 quarters.
  • Psagot Value Holdings's Boston Scientific position peaked at $3.89M in Q3 2021.
  • 1,222 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2024.

Based on Psagot Value Holdings's 13F filing for Q1 2024, filed 15 May 2024.